Put Options

17 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q4 2021

Sep 21, 2023

BUY
$37.06 - $47.11 $355,776 - $452,256
9,600 Added 9600.0%
9,700 $412,000
Q4 2021

Feb 14, 2022

BUY
$37.06 - $47.11 $355,776 - $452,256
9,600 Added 9600.0%
9,700 $413,000
Q3 2021

Sep 21, 2023

SELL
$40.26 - $57.37 $1.44 Million - $2.05 Million
-35,800 Reduced 99.72%
100 $4,000
Q3 2021

Nov 15, 2021

SELL
$40.26 - $57.37 $1.44 Million - $2.05 Million
-35,800 Reduced 99.72%
100 $4,000
Q2 2021

Sep 21, 2023

SELL
$54.88 - $79.29 $1.15 Million - $1.66 Million
-20,900 Reduced 36.8%
35,900 $2.04 Million
Q2 2021

Aug 20, 2021

SELL
$54.88 - $79.29 $195 Million - $282 Million
-3,554,100 Reduced 99.0%
35,900 $2.04 Million
Q2 2021

Aug 16, 2021

BUY
$54.88 - $79.29 $194 Million - $280 Million
3,533,200 Added 6220.42%
3,590,000 $2.04 Million
Q1 2021

Sep 21, 2023

BUY
$70.65 - $96.76 $1.26 Million - $1.73 Million
17,900 Added 46.02%
56,800 $4.25 Million
Q1 2021

May 14, 2021

BUY
$70.65 - $96.76 $1.26 Million - $1.73 Million
17,900 Added 46.02%
56,800 $4.25 Million
Q4 2020

Sep 21, 2023

BUY
$58.41 - $89.06 $2.27 Million - $3.46 Million
38,900 New
38,900 $3.37 Million
Q4 2020

Feb 16, 2021

BUY
$58.41 - $89.06 $1.88 Million - $2.87 Million
32,200 Added 480.6%
38,900 $3.37 Million
Q3 2020

Nov 13, 2020

SELL
$41.13 - $62.45 $2.41 Million - $3.67 Million
-58,700 Reduced 89.76%
6,700 $410,000
Q4 2019

Feb 13, 2020

SELL
$60.18 - $154.77 $583,746 - $1.5 Million
-9,700 Reduced 12.92%
65,400 $4.72 Million
Q3 2019

Nov 13, 2019

BUY
$140.29 - $189.96 $1.74 Million - $2.36 Million
12,400 Added 19.78%
75,100 $10.5 Million
Q2 2019

Aug 14, 2019

SELL
$157.85 - $183.09 $3.43 Million - $3.97 Million
-21,700 Reduced 25.71%
62,700 $11.5 Million
Q1 2019

May 15, 2019

BUY
$89.33 - $163.65 $6.25 Million - $11.5 Million
70,000 Added 486.11%
84,400 $13.4 Million
Q4 2018

Feb 14, 2019

BUY
$81.94 - $139.71 $1.18 Million - $2.01 Million
14,400 New
14,400 $1.38 Million

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.